Does the media refer more to HSCS or MLSS?

In the previous week, HeartSciences had 13 more articles in the media than Milestone Scientific. MarketBeat recorded 14 mentions for HeartSciences and 1 mentions for Milestone Scientific. HeartSciences' average media sentiment score of 0.24 beat Milestone Scientific's score of 0.00 indicating that HeartSciences is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment HeartSciences 2 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Milestone Scientific 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Is NSPR or HSCS more profitable?

HeartSciences has a net margin of 0.00% compared to InspireMD's net margin of -413.96%. InspireMD's return on equity of -69.42% beat HeartSciences' return on equity. Company Net Margins Return on Equity Return on Assets InspireMD -413.96% -69.42% -57.68% HeartSciences N/A -358.60% -144.82%

Does the media prefer NSPR or HSCS?

In the previous week, HeartSciences had 11 more articles in the media than InspireMD. MarketBeat recorded 14 mentions for HeartSciences and 3 mentions for InspireMD. InspireMD's average media sentiment score of 0.25 beat HeartSciences' score of 0.24 indicating that InspireMD is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment InspireMD 0 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral HeartSciences 2 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts prefer QTEX or HSCS?

HeartSciences has a consensus target price of $8.00, indicating a potential upside of 266.97%. Given HeartSciences' stronger consensus rating and higher possible upside, analysts clearly believe HeartSciences is more favorable than Inspira Technologies OXY B.H.N.. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Inspira Technologies OXY B.H.N. 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 HeartSciences 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Which has preferable valuation and earnings, QTEX or HSCS?

HeartSciences has lower revenue, but higher earnings than Inspira Technologies OXY B.H.N.. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Inspira Technologies OXY B.H.N. $290K 111.57 -$13.22M N/A N/A HeartSciences N/A N/A -$9.14M -$3.94 N/A

Is QTEX or HSCS more profitable?

Inspira Technologies OXY B.H.N.'s return on equity of 0.00% beat HeartSciences' return on equity. Company Net Margins Return on Equity Return on Assets Inspira Technologies OXY B.H.N. N/A N/A N/A HeartSciences N/A -358.60% -144.82%

Does the media favor QTEX or HSCS?

In the previous week, HeartSciences had 13 more articles in the media than Inspira Technologies OXY B.H.N.. MarketBeat recorded 14 mentions for HeartSciences and 1 mentions for Inspira Technologies OXY B.H.N.. HeartSciences' average media sentiment score of 0.24 beat Inspira Technologies OXY B.H.N.'s score of 0.00 indicating that HeartSciences is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Inspira Technologies OXY B.H.N. 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral HeartSciences 2 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts rate HSCS or IINN?

HeartSciences currently has a consensus price target of $8.00, indicating a potential upside of 266.97%. Given HeartSciences' stronger consensus rating and higher possible upside, research analysts plainly believe HeartSciences is more favorable than Inspira Technologies OXY B.H.N.. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score HeartSciences 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Inspira Technologies OXY B.H.N. 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has better earnings and valuation, HSCS or IINN?

HeartSciences has higher earnings, but lower revenue than Inspira Technologies OXY B.H.N.. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio HeartSciences N/A N/A -$9.14M -$3.94 N/A Inspira Technologies OXY B.H.N. $289K 111.95 -$13.22M N/A N/A

Is HSCS or IINN more profitable?

Inspira Technologies OXY B.H.N.'s return on equity of 0.00% beat HeartSciences' return on equity. Company Net Margins Return on Equity Return on Assets HeartSciences N/A -358.60% -144.82% Inspira Technologies OXY B.H.N. N/A N/A N/A

Does the media refer more to HSCS or IINN?

In the previous week, HeartSciences had 12 more articles in the media than Inspira Technologies OXY B.H.N.. MarketBeat recorded 14 mentions for HeartSciences and 2 mentions for Inspira Technologies OXY B.H.N.. HeartSciences' average media sentiment score of 0.24 beat Inspira Technologies OXY B.H.N.'s score of 0.00 indicating that HeartSciences is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment HeartSciences 2 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Inspira Technologies OXY B.H.N. 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Is HSCS or TELA more profitable?

HeartSciences has a net margin of 0.00% compared to TELA Bio's net margin of -49.30%. HeartSciences' return on equity of -358.60% beat TELA Bio's return on equity. Company Net Margins Return on Equity Return on Assets HeartSciences N/A -358.60% -144.82% TELA Bio -49.30% -1,320.81% -55.83%

Does the media refer more to HSCS or TELA?

In the previous week, HeartSciences had 13 more articles in the media than TELA Bio. MarketBeat recorded 14 mentions for HeartSciences and 1 mentions for TELA Bio. HeartSciences' average media sentiment score of 0.24 beat TELA Bio's score of 0.00 indicating that HeartSciences is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment HeartSciences 2 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral TELA Bio 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

HeartSciences (HSCS) Competitors

$2.18 0.00 (0.00%)

Closing price 07/31/2026 04:00 PM Eastern

Extended Trading

$2.25 +0.07 (+3.39%)

As of 07/31/2026 07:56 PM Eastern

Compare

HSCS vs. MLSS, NSPR, QTEX, IINN, and TELA

Should you buy HeartSciences stock or one of its competitors? MarketBeat compares HeartSciences with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with HeartSciences include Milestone Scientific (MLSS), InspireMD (NSPR), Inspira Technologies OXY B.H.N. (QTEX), Inspira Technologies OXY B.H.N. (IINN), and TELA Bio (TELA).

How does HeartSciences compare to Milestone Scientific?

HeartSciences (NASDAQ:HSCS) and Milestone Scientific (NYSE:MLSS) are both small-cap healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, earnings, institutional ownership, dividends, valuation, risk and media sentiment.

HeartSciences has a net margin of 0.00% compared to Milestone Scientific's net margin of -52.01%. Milestone Scientific's return on equity of -60.26% beat HeartSciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
HeartSciences	N/A	-358.60%	-144.82%
Milestone Scientific	-52.01%	-60.26%	-40.23%

HeartSciences presently has a consensus target price of $8.00, suggesting a potential upside of 266.97%. Milestone Scientific has a consensus target price of $1.00, suggesting a potential upside of 150.63%. Given HeartSciences' higher possible upside, equities research analysts plainly believe HeartSciences is more favorable than Milestone Scientific.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
HeartSciences	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Milestone Scientific	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00

17.2% of HeartSciences shares are held by institutional investors. Comparatively, 5.8% of Milestone Scientific shares are held by institutional investors. 4.9% of HeartSciences shares are held by company insiders. Comparatively, 9.2% of Milestone Scientific shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Milestone Scientific has higher revenue and earnings than HeartSciences. Milestone Scientific is trading at a lower price-to-earnings ratio than HeartSciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
HeartSciences	N/A	N/A	-$9.14M	-$3.94	N/A
Milestone Scientific	$8.90M	3.96	-$6.93M	-$0.05	N/A

In the previous week, HeartSciences had 13 more articles in the media than Milestone Scientific. MarketBeat recorded 14 mentions for HeartSciences and 1 mentions for Milestone Scientific. HeartSciences' average media sentiment score of 0.24 beat Milestone Scientific's score of 0.00 indicating that HeartSciences is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
HeartSciences	2 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Milestone Scientific	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

HeartSciences has a beta of 1.79, meaning that its stock price is 79% more volatile than the broader market. Comparatively, Milestone Scientific has a beta of 1.05, meaning that its stock price is 5% more volatile than the broader market.

Summary

HeartSciences and Milestone Scientific tied by winning 7 of the 14 factors compared between the two stocks.

How does HeartSciences compare to InspireMD?

InspireMD (NYSE:NSPR) and HeartSciences (NASDAQ:HSCS) are both small-cap healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, dividends, profitability, media sentiment, risk, earnings and valuation.

InspireMD has a beta of 0.78, meaning that its stock price is 22% less volatile than the broader market. Comparatively, HeartSciences has a beta of 1.79, meaning that its stock price is 79% more volatile than the broader market.

HeartSciences has a net margin of 0.00% compared to InspireMD's net margin of -413.96%. InspireMD's return on equity of -69.42% beat HeartSciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
InspireMD	-413.96%	-69.42%	-57.68%
HeartSciences	N/A	-358.60%	-144.82%

HeartSciences has lower revenue, but higher earnings than InspireMD. InspireMD is trading at a lower price-to-earnings ratio than HeartSciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
InspireMD	$10.85M	2.81	-$19.92M	-$0.73	N/A
HeartSciences	N/A	N/A	-$9.14M	-$3.94	N/A

InspireMD presently has a consensus price target of $4.50, indicating a potential upside of 592.31%. HeartSciences has a consensus price target of $8.00, indicating a potential upside of 266.97%. Given InspireMD's stronger consensus rating and higher probable upside, analysts clearly believe InspireMD is more favorable than HeartSciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
InspireMD	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00
HeartSciences	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

44.8% of InspireMD shares are held by institutional investors. Comparatively, 17.2% of HeartSciences shares are held by institutional investors. 34.1% of InspireMD shares are held by insiders. Comparatively, 4.9% of HeartSciences shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

In the previous week, HeartSciences had 11 more articles in the media than InspireMD. MarketBeat recorded 14 mentions for HeartSciences and 3 mentions for InspireMD. InspireMD's average media sentiment score of 0.25 beat HeartSciences' score of 0.24 indicating that InspireMD is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
InspireMD	0 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
HeartSciences	2 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

InspireMD beats HeartSciences on 10 of the 15 factors compared between the two stocks.

How does HeartSciences compare to Inspira Technologies OXY B.H.N.?

Inspira Technologies OXY B.H.N. (NASDAQ:QTEX) and HeartSciences (NASDAQ:HSCS) are both small-cap healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their risk, institutional ownership, profitability, earnings, valuation, media sentiment, analyst recommendations and dividends.

In the previous week, HeartSciences had 13 more articles in the media than Inspira Technologies OXY B.H.N.. MarketBeat recorded 14 mentions for HeartSciences and 1 mentions for Inspira Technologies OXY B.H.N.. HeartSciences' average media sentiment score of 0.24 beat Inspira Technologies OXY B.H.N.'s score of 0.00 indicating that HeartSciences is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Inspira Technologies OXY B.H.N.	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
HeartSciences	2 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Inspira Technologies OXY B.H.N. has a beta of 4.24, suggesting that its stock price is 324% more volatile than the broader market. Comparatively, HeartSciences has a beta of 1.79, suggesting that its stock price is 79% more volatile than the broader market.

HeartSciences has lower revenue, but higher earnings than Inspira Technologies OXY B.H.N..

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Inspira Technologies OXY B.H.N.	$290K	111.57	-$13.22M	N/A	N/A
HeartSciences	N/A	N/A	-$9.14M	-$3.94	N/A

12.7% of Inspira Technologies OXY B.H.N. shares are owned by institutional investors. Comparatively, 17.2% of HeartSciences shares are owned by institutional investors. 29.4% of Inspira Technologies OXY B.H.N. shares are owned by insiders. Comparatively, 4.9% of HeartSciences shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Inspira Technologies OXY B.H.N.'s return on equity of 0.00% beat HeartSciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Inspira Technologies OXY B.H.N.	N/A	N/A	N/A
HeartSciences	N/A	-358.60%	-144.82%

HeartSciences has a consensus target price of $8.00, indicating a potential upside of 266.97%. Given HeartSciences' stronger consensus rating and higher possible upside, analysts clearly believe HeartSciences is more favorable than Inspira Technologies OXY B.H.N..

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Inspira Technologies OXY B.H.N.	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
HeartSciences	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Summary

HeartSciences beats Inspira Technologies OXY B.H.N. on 7 of the 12 factors compared between the two stocks.

How does HeartSciences compare to Inspira Technologies OXY B.H.N.?

HeartSciences (NASDAQ:HSCS) and Inspira Technologies OXY B.H.N. (NASDAQ:IINN) are both small-cap healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, risk, media sentiment, analyst recommendations, profitability, dividends, valuation and earnings.

HeartSciences has higher earnings, but lower revenue than Inspira Technologies OXY B.H.N..

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
HeartSciences	N/A	N/A	-$9.14M	-$3.94	N/A
Inspira Technologies OXY B.H.N.	$289K	111.95	-$13.22M	N/A	N/A

HeartSciences currently has a consensus price target of $8.00, indicating a potential upside of 266.97%. Given HeartSciences' stronger consensus rating and higher possible upside, research analysts plainly believe HeartSciences is more favorable than Inspira Technologies OXY B.H.N..

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
HeartSciences	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Inspira Technologies OXY B.H.N.	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, HeartSciences had 12 more articles in the media than Inspira Technologies OXY B.H.N.. MarketBeat recorded 14 mentions for HeartSciences and 2 mentions for Inspira Technologies OXY B.H.N.. HeartSciences' average media sentiment score of 0.24 beat Inspira Technologies OXY B.H.N.'s score of 0.00 indicating that HeartSciences is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
HeartSciences	2 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Inspira Technologies OXY B.H.N.	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

HeartSciences has a beta of 1.79, indicating that its stock price is 79% more volatile than the broader market. Comparatively, Inspira Technologies OXY B.H.N. has a beta of 2.16, indicating that its stock price is 116% more volatile than the broader market.

Inspira Technologies OXY B.H.N.'s return on equity of 0.00% beat HeartSciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
HeartSciences	N/A	-358.60%	-144.82%
Inspira Technologies OXY B.H.N.	N/A	N/A	N/A

17.2% of HeartSciences shares are held by institutional investors. Comparatively, 12.7% of Inspira Technologies OXY B.H.N. shares are held by institutional investors. 4.9% of HeartSciences shares are held by company insiders. Comparatively, 29.4% of Inspira Technologies OXY B.H.N. shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Summary

HeartSciences beats Inspira Technologies OXY B.H.N. on 7 of the 12 factors compared between the two stocks.

How does HeartSciences compare to TELA Bio?

HeartSciences (NASDAQ:HSCS) and TELA Bio (NASDAQ:TELA) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, risk, valuation, dividends, analyst recommendations, profitability, media sentiment and earnings.

In the previous week, HeartSciences had 13 more articles in the media than TELA Bio. MarketBeat recorded 14 mentions for HeartSciences and 1 mentions for TELA Bio. HeartSciences' average media sentiment score of 0.24 beat TELA Bio's score of 0.00 indicating that HeartSciences is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
HeartSciences	2 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
TELA Bio	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

17.2% of HeartSciences shares are held by institutional investors. Comparatively, 94.3% of TELA Bio shares are held by institutional investors. 4.9% of HeartSciences shares are held by company insiders. Comparatively, 5.1% of TELA Bio shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

HeartSciences has a net margin of 0.00% compared to TELA Bio's net margin of -49.30%. HeartSciences' return on equity of -358.60% beat TELA Bio's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
HeartSciences	N/A	-358.60%	-144.82%
TELA Bio	-49.30%	-1,320.81%	-55.83%

HeartSciences has higher earnings, but lower revenue than TELA Bio. TELA Bio is trading at a lower price-to-earnings ratio than HeartSciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
HeartSciences	N/A	N/A	-$9.14M	-$3.94	N/A
TELA Bio	$80.81M	0.40	-$38.83M	-$0.79	N/A

HeartSciences presently has a consensus target price of $8.00, indicating a potential upside of 266.97%. TELA Bio has a consensus target price of $2.20, indicating a potential upside of 201.41%. Given HeartSciences' higher probable upside, analysts clearly believe HeartSciences is more favorable than TELA Bio.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
HeartSciences	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
TELA Bio	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

HeartSciences has a beta of 1.79, suggesting that its share price is 79% more volatile than the broader market. Comparatively, TELA Bio has a beta of 1.34, suggesting that its share price is 34% more volatile than the broader market.

Summary

HeartSciences beats TELA Bio on 8 of the 15 factors compared between the two stocks.

Get HeartSciences News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding HSCS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

HSCS vs. The Competition

Export

Metric	HeartSciences	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$8.50M	$5.58B	$6.85B	$12.42B
Dividend Yield	N/A	1.79%	2.59%	10.03%
P/E Ratio	-0.55	23.11	282.30	24.66
Price / Sales	N/A	56.82	564.25	75.48
Price / Cash	N/A	32.53	28.60	46.71
Price / Book	31.14	6.29	10.98	6.07
Net Income	-$9.14M	$151.15M	$3.49B	$347.99M
7 Day Performance	-13.83%	1.02%	-0.60%	-0.44%
1 Month Performance	-21.86%	-3.44%	-5.19%	-4.81%
1 Year Performance	-28.52%	2.34%	62.02%	18.61%

HeartSciences Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
HSCS HeartSciences	2.8056 of 5 stars	$2.18 flat	$8.00 +267.0%	-28.5%	$8.50M	N/A	N/A	10	Trending News Analyst Revision Gap Down
MLSS Milestone Scientific	1.2004 of 5 stars	$0.38 -12.6%	$1.00 +166.0%	-7.4%	$33.26M	$8.90M	N/A	30
NSPR InspireMD	3.9212 of 5 stars	$0.67 -2.1%	$4.50 +571.5%	-75.8%	$31.39M	$10.85M	N/A	50
QTEX Inspira Technologies OXY B.H.N.	0.2922 of 5 stars	$0.85 -2.6%	N/A	N/A	$31.38M	$290K	N/A	20	Gap Down
IINN Inspira Technologies OXY B.H.N.	0.0416 of 5 stars	$0.87 -8.1%	N/A	-26.8%	$31.38M	$289K	N/A	20	Upcoming Earnings Gap Up High Trading Volume

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:HSCS) was last updated on 8/3/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

HeartSciences (HSCS) Competitors

HSCS vs. MLSS, NSPR, QTEX, IINN, and TELA

How does HeartSciences compare to Milestone Scientific?

Summary

How does HeartSciences compare to InspireMD?

Summary

How does HeartSciences compare to Inspira Technologies OXY B.H.N.?

Summary

How does HeartSciences compare to Inspira Technologies OXY B.H.N.?

Summary

How does HeartSciences compare to TELA Bio?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

HSCS vs. The Competition

HeartSciences Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

HeartSciences (HSCS) Competitors

HSCS vs. MLSS, NSPR, QTEX, IINN, and TELA

How does HeartSciences compare to Milestone Scientific?

Is HSCS or MLSS more profitable?

Do analysts recommend HSCS or MLSS?

Do institutionals & insiders hold more shares of HSCS or MLSS?

Which has preferable earnings & valuation, HSCS or MLSS?

Does the media refer more to HSCS or MLSS?

Which has more volatility & risk, HSCS or MLSS?

Summary

How does HeartSciences compare to InspireMD?

Which has more risk & volatility, NSPR or HSCS?

Is NSPR or HSCS more profitable?

Which has better valuation and earnings, NSPR or HSCS?

Do analysts rate NSPR or HSCS?

Do institutionals and insiders believe in NSPR or HSCS?

Does the media prefer NSPR or HSCS?

Summary

How does HeartSciences compare to Inspira Technologies OXY B.H.N.?

Does the media favor QTEX or HSCS?

Which has more volatility and risk, QTEX or HSCS?

Which has preferable valuation and earnings, QTEX or HSCS?

Do insiders and institutionals believe in QTEX or HSCS?

Is QTEX or HSCS more profitable?

Do analysts prefer QTEX or HSCS?

Summary

How does HeartSciences compare to Inspira Technologies OXY B.H.N.?

Which has better earnings and valuation, HSCS or IINN?

Do analysts rate HSCS or IINN?

Does the media refer more to HSCS or IINN?

Which has more volatility and risk, HSCS or IINN?

Is HSCS or IINN more profitable?

Do institutionals & insiders have more ownership in HSCS or IINN?

Summary

How does HeartSciences compare to TELA Bio?

Does the media refer more to HSCS or TELA?

Do institutionals and insiders have more ownership in HSCS or TELA?

Is HSCS or TELA more profitable?

Which has higher valuation and earnings, HSCS or TELA?

Do analysts rate HSCS or TELA?

Which has more risk & volatility, HSCS or TELA?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

HSCS vs. The Competition

HeartSciences Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools